Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Dec 19, 2023

BUY
$1.45 - $3.35 $20,632 - $47,667
14,229 Added 109.67%
27,203 $39,000
Q3 2023

Nov 15, 2023

BUY
$1.45 - $3.35 $20,632 - $47,667
14,229 Added 109.67%
27,203 $40,000
Q2 2023

Dec 19, 2023

SELL
$1.89 - $3.86 $211,351 - $431,648
-111,826 Reduced 89.6%
12,974 $41,000
Q2 2023

Aug 15, 2023

SELL
$1.89 - $3.86 $211,351 - $431,648
-111,826 Reduced 89.6%
12,974 $41,000
Q1 2023

Dec 19, 2023

BUY
$1.97 - $3.58 $192,266 - $349,397
97,597 Added 358.77%
124,800 $294,000
Q1 2023

May 15, 2023

BUY
$1.97 - $3.58 $245,856 - $446,784
124,800 New
124,800 $295,000

Others Institutions Holding LYEL

About Lyell Immunopharma, Inc.


  • Ticker LYEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 247,824,992
  • Market Cap $146M
  • Description
  • Lyell Immunopharma, Inc., a T cell reprogramming company, engages in developing T cell therapies for patients with solid tumors. The company develops therapies using technology platforms, such as Gen-R, an ex vivo genetic reprogramming technology to overcome T cell exhaustion; and Epi-R, an ex vivo epigenetic reprogramming technology to generate...
More about LYEL
Track This Portfolio

Track Public Employees Retirement System Of Ohio Portfolio

Follow Public Employees Retirement System Of Ohio and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Public Employees Retirement System Of Ohio, based on Form 13F filings with the SEC.

News

Stay updated on Public Employees Retirement System Of Ohio with notifications on news.